SAM
TYRA icon

Smartleaf Asset Management’s Tyra Biosciences TYRA Stock Holding History

Smartleaf Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08K Hold
127
– – ﹤0.01% 2747
2026
Q1 		$4.39K Hold
127
– – ﹤0.01% 2714
2025
Q4 		$3.23K Buy
+127
New +$2.33K ﹤0.01% 2837

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Smartleaf Asset Management's TYRA Position: Q2 2026 in Review

Smartleaf Asset Management held its Tyra Biosciences (TYRA) position steady in Q2 2026 at 127 shares worth $4.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2747.

Smartleaf Asset Management first reported a position in TYRA in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.39K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Smartleaf Asset Management held 127 shares of Tyra Biosciences worth $4.08K as of Q2 2026.
  • Smartleaf Asset Management left its Tyra Biosciences share count unchanged in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2747 holding.
  • Smartleaf Asset Management first reported a position in Tyra Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Smartleaf Asset Management's Tyra Biosciences position peaked at $4.39K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.